title: Are stem-like cells responsible for resistance to therapy in breast cancer?
authors.affiliation: Breast Biology Group, School of Cancer and Imaging Sciences, Paterson Institute for Cancer Research, University of Manchester, Wilmslow Road, Manchester, M20 4BX, UK.
authors.forename: Ciara S
authors.initials: CS
authors.lastname: O'Brien
authors.forename: Gillian
authors.initials: G
authors.lastname: Farnie
authors.forename: Sacha J
authors.initials: SJ
authors.lastname: Howell
authors.forename: Robert B
authors.initials: RB
authors.lastname: Clarke
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects; D001943:Breast Neoplasms / Q000378:metabolism / Q000473:pathology*; D019008:Drug Resistance, Neoplasm; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D005260:Female; D006801:Humans; D014411:Neoplastic Stem Cells; D011878:Radiotherapy / Q000009:adverse effects; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D011959:Receptors, Estradiol / Q000378:metabolism; D011960:Receptors, Estrogen / Q000378:metabolism; D011980:Receptors, Progesterone / Q000378:metabolism; D017211:Treatment Failure
chemical_list: D000970:Antineoplastic Agents; D066246:ErbB Receptors; D018719:Erb-b2 Receptor Tyrosine Kinases; D011959:Receptors, Estradiol; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone